EligibleTrials

Alpha Lipoic Acid in Ulcerative Colitis

Recruiting · NCT06067698 · Interventional (participants receive a specific treatment) · Lead sponsor: Tanta University

View the official record on ClinicalTrials.gov →
Ulcerative Colitis

Interventions studied

"Mesalamine" and "Placebo""Mesalamine" and "alpha-lipoic acid"

What this trial is about

This study aims at evaluating the efficacy and safety of alpha-lipoic acid as adjuvant therapy to mesalamine in patients with mild to moderate ulcerative colitis due to its effect as anti-oxidant and anti-inflammatory drug which can help to improve disease.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.